SEC Form 4 · accession 0000899243-18-019667

Amneal Pharmaceuticals, Inc. · AMRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Jul 5, 2018

Accepted (ET)

Jul 9, 2018 · 5:15 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001723128

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class B Common Stock^F2	Jul 5, 2018	J	30,384,769	$0.00	A	30,384,769	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Units^F2,F3	—	Jul 5, 2018	J	30,384,769	A	—	—	Common Units	30,384,769	30,384,769	I

F1Represents a pro rata in-kind distribution of Class B Common Stock and Common Units from APHC Holdings, LLC to its members for no consideration.
F2By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis.